273.56MMarket Cap
LossP/E TTM
Key Figures
3.100Open
3.260High
15.16MVolume
LossP/E TTM
19.46P/E Dynamic
--Dividend TTM
15.86%Turnover Ratio
5.370Prev. Close
2.810Low
34.43MTurnover
LossP/E Static
0.90P/B
0.00%Div Yield TTM
-47.61%ROA
8.59052wk High
3.59Volume Ratio
-127.30MNet Profit
95.60MShares
-4.3142EPS TTM
1.77Beta
-76.73%ROE
3.53052wk Low
8.38%Amplitude
66.60%Gross Margin
273.56MMarket Cap
-2.82Reward/Risk
3.89%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Myriad Genetics Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 50 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 6.50.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Myriad Genetics Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Myriad Genetics Inc Highlights
StrengthsRisks
Myriad Genetics Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Myriad Genetics Inc Info
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health, and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test, which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor, Precise Liquid, SneakPeek and GeneSight, among others.
Ticker SymbolMYGN
CompanyMyriad Genetics Inc
CEORaha (Samraat S)
Websitehttps://myriad.com/
Shareholders
FAQs
What is the current price of Myriad Genetics Inc (MYGN)?
The current price of Myriad Genetics Inc (MYGN) is 2.86.
What is the symbol of Myriad Genetics Inc?
The ticker symbol of Myriad Genetics Inc is MYGN.
What is the 52-week high of Myriad Genetics Inc?
The 52-week high of Myriad Genetics Inc is 8.59.
What is the 52-week low of Myriad Genetics Inc?
The 52-week low of Myriad Genetics Inc is 3.53.
What is the market capitalization of Myriad Genetics Inc?
The market capitalization of Myriad Genetics Inc is 273.42M.
Is Myriad Genetics Inc (MYGN) currently rated as Buy, Hold, or Sell?
According to analysts, Myriad Genetics Inc (MYGN) has an overall rating of signal_hold, with a price target of 6.50.
What is the Earnings Per Share (EPS TTM) of Myriad Genetics Inc (MYGN)?
The Earnings Per Share (EPS TTM) of Myriad Genetics Inc (MYGN) is -3.95.
